Correspondence 0001193125-24-142945 from Korro Bio, Inc. (KRRO) (CIK 0001703647) (KRRO)
Korro Bio, Inc. (KRRO) (CIK 0001703647)
Date: May 20, 2024 · CIK: 0001703647 · Accession: 0001193125-24-142945
AI Filing Summary & Sentiment
File numbers found in text: 333-279402
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Attention: Requested Date: May 22, 2024 Requested Time: 4:05 p.m., Eastern Time
Dear Mr. Edwards:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Korro Bio, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to May 22, 2024, at 4:05 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP, by calling Marianne Sarrazin at (415) 733-6134.
If you have any questions regarding this request, please contact Marianne Sarrazin of Goodwin Procter LLP at (415) 733-6134.
Sincerely,
KORRO BIO, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP VIA EDGAR May 20, 2024 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Mr. Chris Edwards Re: Korro Bio, Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-279402 Acceleration Request Requested Date: May 22, 2024 Requested Time: 4:05 p.m., Eastern Time Dear Mr. Edwards: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Korro Bio, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to May 22, 2024, at 4:05 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP, by calling Marianne Sarrazin at (415) 733-6134. If you have any questions regarding this request, please contact Marianne Sarrazin of Goodwin Procter LLP at (415) 733-6134. Sincerely, KORRO BIO, INC. /s/ Vineet Agarwal Vineet Agarwal Chief Financial Officer Korro Bio, Inc. cc: Ram Aiyar, President, Chief Executive Officer and Director, Korro Bio, Inc. Shelby Walker, General Counsel, Korro Bio, Inc. Kingsley L. Taft, Esq., Goodwin Procter LLP Marianne Sarrazin, Esq., Goodwin Procter LLP